NeuScience Company
NeuScience uses computer vision to detect phenotypic signals, resulting in a novel, pan-cancer biomarkers. The company's biological assay pairs the heterogeneity of patient tumor panels with the precision of single-cell phenotypic screening.
NeuScience uses clinically-validated phenotypes and deep learning to discover novel single-cell biomarkers related to tumorigenesis, metastasis, toxicity, and drug resistance.
The company was founded in 2018 by Guillermo Vela and Nicole Romano.
Investors
Connections from
Founded Date:
2018-01-01
Industry:
Quantum Biology
Last Funding Date:
2019-01-17
Funding Status:
private
Headquarters:
San Antonio,Texas,United States,North America
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Founders:
Guillermo Vela,Nicole Romano